Maplebear (CART), better known as Instacart, posted better-than-expected results as shoppers placed more orders and spent more money on them.

LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) -- So Cal Gyms, LLC, a Planet Fitness Franchisee, has opened its newest location in Los Angeles in the Hyde Park neighborhood at 3230 W. Slauson Ave.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming November 12, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired V.F. Corporation (“VFC” or the “Company”) (NYSE: VFC) securities between October 27, 2022 and May 20, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON V.F. CORPORATION (VFC), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAU.

Regeneron Pharmaceuticals, Inc. ( REGN ) Discusses Factor XI Development Program and Clinical Data in Hematology Pipeline November 10, 2025 8:30 AM EST Company Participants Ryan Crowe - Senior Vice President of Investor Relations & Strategic Analysis George Yancopoulos - Co-Founder, President, Chief Scientific Officer & Co-Chairman L. Sirulnik - Senior Vice President of Clinical Development Unit Head & Hematology David Gutstein Conference Call Participants Brian Abrahams - RBC Capital Markets, Research Division Tyler Van Buren - TD Cowen, Research Division David Risinger - Leerink Partners LLC, Research Division Simon Baker - Rothschild & Co Redburn, Research Division Malcolm Hoffman …

LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 23, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX) common stock (previously American Depositary Shares until the Company's conversion to common stock on July 1, 2025) between May 20, 2025 and August 18, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR JAMES HARDIE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS …

Cogent Biosciences, Inc. earns a Strong Buy rating due to positive phase 3 PEAK results for bezuclastinib + Sunitinib in 2nd-line GIST. Company's combination therapy showed a significant mPFS improvement (16.5 vs. 9.2 months) and higher ORR (46% vs. 26%) over Sunitinib monotherapy in 2nd-line GIST patients. Upcoming catalysts include NDA filings for GIST in 1H 2026 and NonAdvSM by end of 2025, plus phase 2 APEX results for AdvSM in December 2025.

Monday.com's NASDAQ: MNDY Q3 earnings release provided an excuse to sell, but the 20% decline posted in premarket action is an overreaction of epic proportions. The cause was guidance.

New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Tandem Diabetes Care securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

John Ketchum, NextEra CEO, joins 'The Exchange' to discuss Google's deal with NextEra Energy, if it'll be accretive to earnings and much more.

Apple will delay the next version of the iPhone Air amid weak sales and it will not be released in the fall of 2026, the Information reported on Monday, citing sources familiar with the matter.

FLR posts stronger-than-expected Q3 earnings but lower revenues, as project activity increases and 2025 guidance is raised.

WEYS' Q3 earnings slip 18% year over year amid tariff pressures and softer consumer demand. Management is shifting sourcing strategies and declared a special $2 dividend alongside its regular payout.

CEVA, Inc. ( CEVA ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Richard Kingston - Vice President of Market Intelligence, Investor & Public Relations Amir Panush - CEO & Director Yaniv Arieli - CFO & Treasurer Conference Call Participants Chris Reimer - Barclays Bank PLC, Research Division Madison De Paola Martin Yang - Oppenheimer & Co. Inc., Research Division David O'Connor - BNP Paribas, Research Division Presentation Operator Good day, and welcome to the CEVA, Inc. Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note today's event is being recorded.

Camtek Ltd. ( CAMT ) Q3 2025 Earnings Call November 10, 2025 9:00 AM EST Company Participants Kenny Green Rafi Amit - CEO & Director Moshe Eisenberg - Chief Financial Officer Ramy Langer - Chief Operating Officer Conference Call Participants Yu Shi - Needham & Company, LLC, Research Division Brian Chin - Stifel, Nicolaus & Company, Incorporated, Research Division Matthew Prisco - Cantor Fitzgerald & Co., Research Division Craig Ellis - B.

Reddit's strong ad growth, global expansion, and AI-driven tools help the company to justify its premium valuation.

CINT's Q3 results are likely to have gained from AI-driven modernization and FLOW integration, while softness in key verticals may have offset growth.

The Zacks Internet - Content industry participants like WBTN and WB are benefiting from expanding mobile, digital and cloud-based offerings amid challenging global macroeconomic conditions.

FUFU is set to post Q3 results, with revenue projected to surge 43% as mining and hosting capacity hit record highs.

Palantir Technologies (PLTR) possesses solid growth attributes, which could help it handily outperform the market.

Celestica (CLS) could produce exceptional returns because of its solid growth attributes.